Abiopharma

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest of Substantial Shareholder - Temasek Holdings (Private) Limited

Boost Run Secures Long-Term Lease with 10X Capital to Expand GPU Compute Capacity

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL OF SGX

Financial Statements and Related Announcement: Half Yearly Results

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Mandatory Cash Dividend/ Distribution:

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results